当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
Slynd
儿科标签批准日期
2019/5/23 0:00:00
特定指示/秒
Prevention of pregnancy
标签更改摘要
- Safety and efficacy have been established in females of reproductive age. Safety and efficacy are expected to be the same for post-pubertal adolescents under the age of 16 and users 16 years and older.
- Study CF111/304 evaluated the bleeding associated with Slynd in females ≥12 years of age. Bleeding data were generally consistent with those from Study CF111/303 in adult females.
- Use of this product before menarche is not indicated.
- New dosage form.